PRODUCT INFORMATION
Description
Cyclo(Arg-Gly-Asp-D-Phe-Cys) TFA is a conformationally constrained cyclic pentapeptide exhibiting selective binding affinity for αvβ3 integrin. This peptide has been shown to suppress pluripotency-associated gene expression in embryonic stem cells in vitro. It is also used to inhibit tumorigenesis in animal models, demonstrating its utility as a research tool in oncology and stem cell biology.
Molecular Weight
692.66
Purity
> 95%
Formula
C₂₆H₃₅F₃N₈O₉S
Product Type
Targeting Peptide
Sequence
Cyclo[Arg-Gly-Asp-D-Phe-Cys]
Form (20 deg.C)
Solid
Storage Condition
Store sealed at -20°C, away from moisture and light.
For Research Use Only | Not For Clinical Use
Related products
- rTAT Targeting Peptide (CAT#: OLY-1025-YS-20)
- T9 Targeting Peptide (CAT#: OLY-1025-YS-19)
- FFAGLDD TFA Targeting Peptide (CAT#: OLY-1025-YS-49)
- CREKA Targeting Peptide (CAT#: OLY-1025-YS-18)
- WLSEAGPVVTVRALRGTGSW TFA Targeting Peptide (CAT#: OLY-1025-YS-67)
- NBD-LLLLpY Targeting Peptide (CAT#: OLY-1025-YS-50)
- CGGRGD Targeting Peptide (CAT#: OLY-1025-YS-26)
- PSMA Targeting Peptide (CAT#: OLY-1025-YS-8)
Online Inquiry
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.